Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, Parallele BioScience, Affymetrix

Premium

Affymetrix and Parallele BioScience this week launched a series of MegAllele assays for SNP genotyping, the companies said in a statement. The assays run on Affy's GeneChip 3000 and the new line is available with a four-color capability for "easily and cost- effectively" genotyping panels containing as many as 10,000 custom or pre-defined SNPs, the companies said.


Affymetrix this week also launched the GeneChip Scanner 3000 7G, whichcan analyze microarrays featuring "500 percent more data than previous generations," the company said. The platform can scan features "ranging in size from 2.5 um to 0.51um," and it "supports the latest high-density GeneChip microarrays for tiling, all-exon and single nucleotide polymorphism genotyping research, the company said.

Filed under

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.